K
KSS Line Ltd
KRX:044450
KSS Line Ltd
KRX:044450
Price:
8 880
KRW
2.19%
Market Closed
Market Cap:
200.5B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
KSS Line Ltd
8880
+190 (+2.19%)
| 52 Week Range |
7 800
9 830
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
KSS Line Ltd
Balance Sheet
Balance Sheet Decomposition
KSS Line Ltd
KSS Line Ltd
| Current Assets | 169.3B |
| Cash & Short-Term Investments | 102.8B |
| Receivables | 33.8B |
| Other Current Assets | 32.8B |
| Non-Current Assets | 1.6T |
| Long-Term Investments | 10.2B |
| PP&E | 1.5T |
| Intangibles | 1.5B |
| Other Non-Current Assets | 26.6B |
| Current Liabilities | 341.3B |
| Accounts Payable | 20.3B |
| Accrued Liabilities | 14.2B |
| Short-Term Debt | 91.9B |
| Other Current Liabilities | 215B |
| Non-Current Liabilities | 948.9B |
| Long-Term Debt | 939.3B |
| Other Non-Current Liabilities | 9.7B |
Balance Sheet
KSS Line Ltd
KSS Line Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
7 252
|
6 641
|
15 045
|
48 838
|
24 315
|
39 625
|
50 971
|
38 035
|
32 532
|
69 636
|
|
| Cash |
33
|
167
|
0
|
2
|
4
|
3
|
3
|
4
|
3
|
1
|
|
| Cash Equivalents |
7 219
|
6 474
|
15 045
|
48 836
|
24 311
|
39 622
|
50 968
|
38 030
|
32 529
|
69 635
|
|
| Short-Term Investments |
2 740
|
2 317
|
1 793
|
1 223
|
1 272
|
1 463
|
860
|
888
|
939
|
222
|
|
| Total Receivables |
5 378
|
18 684
|
9 602
|
9 628
|
8 926
|
10 881
|
8 496
|
9 825
|
22 036
|
24 105
|
|
| Accounts Receivables |
4 451
|
3 863
|
8 757
|
8 383
|
8 060
|
9 763
|
6 097
|
8 291
|
18 259
|
21 538
|
|
| Other Receivables |
927
|
14 821
|
845
|
1 245
|
866
|
1 118
|
2 399
|
1 534
|
3 776
|
2 567
|
|
| Inventory |
3 976
|
3 211
|
3 324
|
5 688
|
7 674
|
10 608
|
10 609
|
17 820
|
18 737
|
19 159
|
|
| Other Current Assets |
2 831
|
3 124
|
2 071
|
2 562
|
2 785
|
1 644
|
1 560
|
1 566
|
8 288
|
20 577
|
|
| Total Current Assets |
22 177
|
33 977
|
31 834
|
67 939
|
44 972
|
64 222
|
72 496
|
68 133
|
82 532
|
133 699
|
|
| PP&E Net |
456 529
|
510 079
|
612 913
|
833 657
|
854 523
|
888 761
|
990 959
|
1 353 047
|
1 546 388
|
1 491 364
|
|
| PP&E Gross |
456 529
|
510 079
|
612 913
|
833 657
|
854 523
|
888 761
|
990 959
|
1 353 047
|
1 546 388
|
1 491 364
|
|
| Accumulated Depreciation |
95 550
|
120 823
|
148 932
|
142 895
|
180 502
|
219 007
|
246 819
|
329 302
|
405 332
|
427 203
|
|
| Intangible Assets |
434
|
423
|
408
|
491
|
461
|
511
|
492
|
530
|
819
|
821
|
|
| Note Receivable |
15 178
|
0
|
0
|
0
|
0
|
0
|
0
|
964
|
203
|
47
|
|
| Long-Term Investments |
471
|
1 044
|
1 731
|
1 768
|
1 735
|
2 772
|
2 780
|
7 802
|
7 604
|
7 868
|
|
| Other Long-Term Assets |
148
|
158
|
1 102
|
908
|
942
|
972
|
2 801
|
15 753
|
21 626
|
22 235
|
|
| Total Assets |
494 936
N/A
|
545 680
+10%
|
647 988
+19%
|
904 763
+40%
|
902 633
0%
|
957 238
+6%
|
1 069 528
+12%
|
1 446 229
+35%
|
1 659 173
+15%
|
1 656 035
0%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
5 398
|
7 884
|
4 485
|
4 453
|
9 125
|
8 894
|
5 791
|
13 817
|
19 052
|
17 062
|
|
| Accrued Liabilities |
1 022
|
1 009
|
1 197
|
1 911
|
2 583
|
2 374
|
2 404
|
9 818
|
14 962
|
13 238
|
|
| Short-Term Debt |
8 647
|
26 121
|
17 806
|
54 421
|
32 306
|
55 576
|
70 048
|
73 405
|
87 684
|
65 838
|
|
| Current Portion of Long-Term Debt |
47 367
|
42 623
|
51 660
|
61 918
|
61 790
|
84 249
|
141 159
|
267 350
|
227 484
|
200 517
|
|
| Other Current Liabilities |
6 926
|
9 373
|
9 507
|
12 675
|
16 036
|
17 093
|
20 687
|
17 208
|
29 437
|
39 276
|
|
| Total Current Liabilities |
69 360
|
87 010
|
84 655
|
135 377
|
121 840
|
168 187
|
240 089
|
381 598
|
378 620
|
335 931
|
|
| Long-Term Debt |
230 990
|
237 162
|
317 518
|
531 521
|
519 463
|
495 576
|
550 921
|
712 582
|
867 030
|
890 929
|
|
| Deferred Income Tax |
2 298
|
2 348
|
2 415
|
2 013
|
1 955
|
1 870
|
1 608
|
2 437
|
1 875
|
1 769
|
|
| Minority Interest |
0
|
0
|
50
|
19
|
3
|
74
|
75
|
73
|
0
|
0
|
|
| Other Liabilities |
7 939
|
7 031
|
7 391
|
8 467
|
9 980
|
10 606
|
8 054
|
6 787
|
5 368
|
6 926
|
|
| Total Liabilities |
310 587
N/A
|
333 550
+7%
|
412 028
+24%
|
677 397
+64%
|
653 235
-4%
|
676 312
+4%
|
800 747
+18%
|
1 103 477
+38%
|
1 252 892
+14%
|
1 235 555
-1%
|
|
| Equity | |||||||||||
| Common Stock |
5 796
|
5 796
|
11 593
|
11 593
|
11 593
|
11 593
|
11 593
|
11 593
|
11 593
|
11 593
|
|
| Retained Earnings |
161 795
|
183 245
|
194 312
|
214 982
|
229 202
|
252 509
|
260 296
|
308 786
|
345 425
|
353 238
|
|
| Additional Paid In Capital |
9 304
|
9 304
|
3 457
|
3 457
|
3 438
|
3 438
|
3 438
|
3 438
|
3 438
|
3 438
|
|
| Unrealized Security Profit/Loss |
253
|
35
|
14
|
104
|
104
|
104
|
104
|
0
|
0
|
0
|
|
| Treasury Stock |
976
|
7 045
|
1 358
|
3 629
|
6 107
|
5 552
|
5 552
|
5 552
|
3 614
|
3 614
|
|
| Other Equity |
8 683
|
20 793
|
27 941
|
859
|
11 168
|
18 834
|
1 097
|
24 487
|
49 439
|
55 826
|
|
| Total Equity |
184 350
N/A
|
212 130
+15%
|
235 960
+11%
|
227 366
-4%
|
249 398
+10%
|
280 926
+13%
|
268 781
-4%
|
342 752
+28%
|
406 280
+19%
|
420 480
+3%
|
|
| Total Liabilities & Equity |
494 936
N/A
|
545 680
+10%
|
647 988
+19%
|
904 763
+40%
|
902 633
0%
|
957 238
+6%
|
1 069 528
+12%
|
1 446 229
+35%
|
1 659 173
+15%
|
1 656 035
0%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
23
|
22
|
23
|
23
|
22
|
22
|
22
|
22
|
23
|
23
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
